CorMedix Inc. Reports Second Quarter 2016 Financial Results and Provides Business Updates

Go back to CorMedix Inc. Reports Second Quarter 2016 Financial Results and Provides Business Updates

CorMedix (CRMD) Misses Q2 EPS by 2c

August 5, 2016 8:39 AM EDT

CorMedix (NYSE: CRMD) reported Q2 EPS of ($0.13), $0.02 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $16.51 million, versus $119.97 million reported last year.

For earnings history and earnings-related data on CorMedix (CRMD) click here.

... More